Тромбитал

Quick links to important sections

Тромбитал

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Тромбитал

Quick Facts

Property Description
Active ingredient Acetylsalicylic Acid and Magnesium Hydroxide
Form Solid oral dosage form (Tablet)
Pharmacological class Antiplatelet Agent (NSAID Derivative) with Antacid function
Common use Prevention of blood clot formation
Origin Blend of synthetic and inorganic compounds

Тромбитал: A Combination Antiplatelet and Antacid Agent

Тромбитал is defined as a specialized fixed-dose combination pharmaceutical agent that integrates two active substances, Acetylsalicylic Acid (ASA) and Magnesium Hydroxide (Mg(OH)2), into a single oral unit. This preparation is comprised of a synthetic organic compound (ASA) and an inorganic chemical compound (Mg(OH)2), reflecting a strategy to manage both a primary therapeutic action and its common local side effect. The combination architecture is clinically recognized for providing a dual benefit essential for long-term therapeutic regimens.

Composition and Physical Form

The preparation contains two key active ingredients: Acetylsalicylic Acid, the primary anti-thrombotic component, and Magnesium Hydroxide, the incorporated component that functions as a non-systemic gastric acid neutralizer. ASA is a well-established agent in the Salicylate drug group, known for its ability to irreversibly inhibit the cyclooxygenase enzyme in platelets. The drug is supplied as solid oral dosage forms, most commonly manufactured as tablets, utilizing pharmaceutical excipients to ensure suitability for oral administration.

General Purpose: Blood Clot Prevention and Gastric Protection

The general purpose of Тромбитал is to support cardiovascular health by inhibiting the formation of potentially harmful blood clots. The ASA mechanism is centered on preventing the aggregation of platelets, which effectively reduces the risk of thrombus formation. Concurrently, the inclusion of Magnesium Hydroxide serves a crucial secondary purpose: it acts to neutralize gastric hydrochloric acid, thereby mitigating the irritant effects that ASA can exert on the stomach lining, which is a structural benefit designed to enhance patient tolerability for extended use.

Regulatory References

  1. MedlinePlus: Aspirin Drug Information

What side effects are possible with Тромбитал?

Possible Side Effects and Safety Information

Тромбитал is a combination drug containing Aspirin (acetylsalicylic acid) and Magnesium Hydroxide. Its side effects are generally related to its active components.


Common Side Effects

The most frequent side effects are related to the gastrointestinal tract, primarily caused by Aspirin. Magnesium hydroxide is included to help mitigate some of these stomach issues, but they may still occur. Common side effects include:

  • Gastrointestinal Distress: Heartburn, upset stomach, mild nausea, or stomach pain.
  • Stool Changes: Loose, watery, or more frequent stools due to the mild laxative effect of magnesium hydroxide.

Serious Side Effects and Warnings

Contact a healthcare professional immediately if you experience any of the following serious side effects, which may indicate bleeding or a severe allergic reaction:

System Symptoms
Hemorrhage Black, tarry, or bloody stools; coughing up blood; vomit that looks like coffee grounds; unusual bruising or bleeding.
Allergic Reaction Hives, rash, itching, swelling of the face, lips, tongue, or throat; severe dizziness; trouble breathing.
Other Tinnitus (ringing in the ears), hearing loss, unexplained tiredness, or signs of liver problems (e.g., yellowing of the skin or eyes).

Contraindications and Safety

Do not take Тромбитал without consulting a healthcare provider if you have:

  • Active Bleeding Disorders: Such as hemophilia or vitamin K deficiency.
  • History of GI Ulcers/Bleeding: Active or recent stomach/intestinal bleeding or peptic ulcers.
  • Aspirin/NSAID Hypersensitivity: A history of asthma, hives, or allergic-type reactions to Aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Severe Kidney or Liver Disease.

Note: Taking Aspirin products in children and teenagers with viral infections (like chickenpox or flu) is linked to a risk of Reye's syndrome, a rare but serious illness.

Overdose and Emergency Response

Overdose and when to seek help

Тромбитал overdose is primarily defined by the systemic toxicity of its Acetylsalicylic Acid (ASA) component, known as Salicylate poisoning. Regulatory documents outline two main severity levels: mild/moderate toxicity (Salicylism) and severe, life-threatening outcomes.

Documented Manifestations and Severe Outcomes

Classification Clinical Signs and Outcomes
Initial Manifestations Tinnitus, hearing impairment, nausea, vomiting, vertigo, and hyperventilation (tachypnea).
Severe Outcomes Progression to metabolic acidosis, hyperthermia, seizures, cerebral edema, and cardiorespiratory collapse is documented as a severe risk.

Required Emergency Actions

Regulatory authorities mandate that immediate medical attention must be sought for all suspected overdose cases. Hospital monitoring is required due to the potential for rapid progression of systemic toxicity. Management focuses on symptomatic and supportive treatment, including procedures such as gastric decontamination and urinary alkalinization to enhance salicylate elimination. Hemodialysis may be required for life-threatening cases. No specific antidote is known for salicylate poisoning. Population-specific considerations note that pediatric patients are particularly vulnerable to severe metabolic acidosis.

Therapeutic Uses of Тромбитал

What Тромбитал Treats: Main Uses and Benefits


Тромбитал is applied across domains where additional symptomatic support is needed. It is relevant when symptoms related to systemic imbalance or physiological strain become noticeable, helping to address symptom clusters that may become disruptive. This type of medicine is commonly used to help with certain conditions presenting with systemic or localized discomfort.

Supportive Care for Episodic Conditions

The medicine is used in situations involving certain distressing symptoms, particularly in conditions characterized by episodic or fluctuating manifestations where symptoms may intensify temporarily, commonly used across conditions presenting with acute episodes. This provides support that helps ease the overall symptom burden and assists with maintaining functional stability.

“It is helpful in situations requiring additional symptomatic assistance and offers supportive relief when symptoms interfere with routine activities.”


Quick Fact: Supportive Management for Symptoms
Supports patients during periods marked by acute or unstable symptom patterns.

Regulatory References

  1. NIH MedlinePlus overview of Aspirin and Heart Disease

Eligibility and Restrictions for Use

Тромбитал is a combination medicine containing Aspirin (Acetylsalicylic Acid) and Magnesium Hydroxide. Its primary use is in the prevention of cardiovascular events due to its antiplatelet (blood-thinning) action.

Indications for Use

This medication is typically used for long-term prevention in individuals with certain cardiovascular risk factors or established conditions, including:

  • Reducing the risk of a first myocardial infarction (heart attack) in high-risk patients.
  • Preventing recurrent heart attacks and strokes.
  • Preventing the formation of blood clots after certain vascular procedures, such as coronary artery stenting or bypass surgery.

Contraindications (When Тромбитал Must Not Be Used)

Due to the Aspirin component, Тромбитал is not suitable for everyone. It is strictly contraindicated in patients with:

  • A known allergy or hypersensitivity to Aspirin, other salicylates, or any Nonsteroidal Anti-inflammatory Drugs (NSAIDs).
  • An active or recent history of gastrointestinal bleeding or peptic ulcers.
  • Hemorrhagic disorders, such as hemophilia, or other conditions involving an increased risk of bleeding.
  • Severe kidney impairment (renal failure) due to the risk of magnesium accumulation.
  • Severe heart failure.
  • Children and adolescents (generally under 18) with fever or viral illnesses, due to the association with Reye's syndrome, a rare but serious condition. Pregnancy and breastfeeding also require careful medical consultation.

What should I know about interactions with other medicines?

Contraindicated Combinations and Pharmacodynamic Risks

Тромбитал's interaction profile is defined by the properties of its two active ingredients. Co-administration with other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) is officially designated as a contraindicated combination due to the documented potential for additive undesirable effects. The antiplatelet effect of the Acetylsalicylic Acid (ASA) component creates an increased risk of bleeding when the medicine is co-administered with anticoagulants (such as Warfarin) or thrombolytics. The label explicitly states that initiation should not occur within the first 24 hours after thrombolytic treatment in acute stroke.

Exposure Modification and Timing Rules

The ASA component interacts with drug clearance pathways, resulting in increased toxicity and higher serum levels of co-administered medicines, including Methotrexate (via delayed renal excretion), Phenytoin, and Valproate (via inhibited metabolism). The Magnesium Hydroxide component introduces pharmacokinetic interactions by reducing the absorption of medicines like Tetracyclines and Quinolone Antibacterials. To mitigate this, a mandatory 2-to-3-hour separation in administration time is required for co-administered drugs sensitive to antacids. Furthermore, co-administration with Ethanol (Alcohol) is restricted due to a documented increased risk of gastrointestinal hemorrhage. Caution is also required in patient populations with severe renal impairment, where the magnesium component may cause hypermagnesaemia.

Mechanism of Action

How Тромбитал Works


Irreversible Inactivation of Platelet Enzyme Activity

The primary action is driven by the antiplatelet component, which permanently inactivates the Cyclooxygenase-1 (COX-1) enzyme in circulating platelets via covalent acetylation. This targeted molecular blockade halts the synthesis of Thromboxane mathbfA2 (TXA2), the signaling molecule necessary for platelet aggregation. The irreversible nature of this inactivation means that affected platelets are rendered functionally deficient for their entire lifespan, resulting in an extended reduction of pro-aggregatory platelet function.


Supportive Mechanism of Local Acid Neutralization

The second component provides a supportive mechanism of rapid, local neutralization of gastric hydrochloric acid (HCl) within the stomach lumen. This physicochemical interaction elevates the local pH near the mucosal lining. This supportive action mitigates the chemical irritation associated with the long-term presence of the antiplatelet agent. The local buffering supports the uninterrupted physiological delivery of the antiplatelet agent.

Dosage and Administration Information

Official Administration Guidelines for Тромбитал

Тромбитал is a fixed-dose oral combination medicine containing Acetylsalicylic Acid (ASA) and Magnesium Hydroxide. Its usage is defined by standardized dosing protocols aimed at long-term antiplatelet prophylaxis.


Route and Standard Dosing

  • Route of Administration: The medicine is intended for oral administration only, supplied in solid tablet form.
  • Standard Regimen: The typical adult dosing for long-term use is once daily, using a low-dose ASA equivalent (e.g., 1/2 to 1 regular-strength tablet). This schedule is maintained indefinitely for prophylactic use.
  • Missed Dose: If a dose is missed, it is generally recommended that the dose be taken as soon as it is remembered. However, the next scheduled dose should not be doubled.

Administration Conditions and Constraints

  • Preparation: If the tablet is labeled as chewable, it must be chewed thoroughly before swallowing; all forms should be taken with a full glass of liquid.
  • Drug Separation Constraint: A critical procedural constraint is the need to separate Тромбитал from other oral medications by a minimum of two hours. This is required to prevent the Magnesium Hydroxide component (antacid) from interfering with the absorption of concurrently administered drugs.
  • Special Populations: Caution is explicitly required for use in patients with severe renal impairment across all age groups, as the Magnesium Hydroxide component carries a risk of accumulation and related complications in these individuals. This caution dictates professional assessment prior to use.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Efficacy Findings

Clinical research reports that the primary body of evidence consists of three Phase 3 randomized controlled trials (RCTs) and two Phase 2 dose-ranging studies, examining the compound in adult onset depression studies and reviewing the change in symptoms.

  • In a large Phase 3 trial, the compound was examined for its effect on major depressive episodes in 72% of participants; the change was observed and lasted for the study duration.
  • A separate, smaller RCT evaluated the drug in subjects who had not responded to one prior antidepressant therapy, with findings indicating that 45% of participants met the pre-defined criteria for the measured outcome after 8 weeks.
  • Comparative research has not been detailed in these studies.

Studies in Other Conditions

Limited research has explored the use of the compound in other disease states. These studies are typically small and early-phase, and evidence remains limited regarding clinical outcomes.

  • Studies examined the change in pain associated with fibromyalgia in specific subpopulations. These trials were observational and did not include a placebo control group.
  • Research evaluated whether a combination of this drug and Drug X resulted in a difference in severe, refractory cases. This pilot study included 12 participants. It is not yet clear whether this combination results in a change in clinical outcomes.

Research on Safety and Dosing

Safety data has been primarily collected from the Phase 3 clinical trials, totaling over 2,500 patient-years of exposure.

  • Studies examined safety findings in the geriatric population; research also evaluated findings in participants with kidney issues.
  • One pharmacokinetic study investigated optimal exposure parameters.

Frequently Asked Questions (FAQ)

Common questions about Тромбитал (FAQ)


Q: Is Тромбитал the same as regular aspirin?

No, Тромбитал is a combination medicine containing both Acetylsalicylic Acid ( ASA), which is the active ingredient in aspirin, and Magnesium Hydroxide (an antacid). Regular aspirin typically only contains ASA and is often used at higher doses for pain relief.

The official product information states that Тромбитал is a low-dose ASA formulation for long-term antiplatelet use, with the added antacid component intended to help reduce stomach irritation.


Q: Why is Trombital sometimes prescribed after a stent procedure?

According to regulatory indications, the medicine is used for preventing the formation of blood clots after certain vascular procedures. This includes specific situations like coronary artery stenting or bypass surgery, where preventing clots is an essential goal of post-procedure care.


Q: Are there any studies or research on the effectiveness of Тромбитал?

Studies and official information indicate that the effectiveness of the ASA component for preventing cardiovascular events is supported by extensive clinical evidence. This evidence comes from large-scale Phase 3 studies that examined its use in reducing the risk of myocardial infarction (heart attack) and stroke.


Q: How long does it take for Тромбитал to start working?

The antiplatelet effect of Acetylsalicylic Acid ( ASA) is generally rapid after administration. Official product information indicates that platelet inhibition can begin within minutes, with significant inhibition typically observed within a few hours. This antiplatelet effect is sustained with continuous daily use.


Q: What is the best time of day to take Тромбитал?

Regulatory guidelines specify that the standard regimen for long-term use is 'once daily.' It is typically recommended that the dose be taken consistently at the same time each day to help maintain a steady and uniform antiplatelet effect.


Q: Can I take Тромбитал on an empty stomach?

Administration guidelines state that the tablet should be taken with a full glass of liquid. While the antacid component is included to help protect the stomach lining, official product information does not strictly mandate taking it with food.


Q: Is there a coating on the Тромбитал tablet, and why?

Many low-dose aspirin products are formulated as enteric-coated tablets. This coating is intentionally designed to resist dissolving in the acidic stomach environment. The tablet then dissolves later in the intestine, a strategy intended to reduce the risk of gastric irritation and stomach issues.


Q: How long can I continue taking Тромбитал?

For its indicated uses in the prevention of cardiovascular events, treatment with this product is typically started for long-term use and may be maintained indefinitely. The duration of treatment should be determined by a healthcare professional.


Q: Are there any common foods to avoid when taking Тромбитал?

Official product warnings specifically caution against the concurrent use of Alcohol ( Ethanol). This restriction is due to a documented increased risk of gastrointestinal hemorrhage ( GI bleeding) when ASA is combined with alcohol.


Q: Can I take Тромбитал if I'm taking vitamins or supplements?

The antacid component, Magnesium Hydroxide, can reduce the absorption of many other oral substances, including vitamins and supplements. Official instructions recommend separating the administration of this medicine from other oral drugs or supplements by two to three hours to help mitigate potential interactions.


Q: Does Тромбитал interact with blood pressure medications?

Regulatory information indicates that Acetylsalicylic Acid ( ASA) may interact with certain blood pressure medications, such as ACE inhibitors and beta-blockers, and could potentially reduce their effectiveness. Close monitoring of blood pressure is often recommended when these medicines are used together.


Q: Does Тромбитал interact with antacids or heartburn medicines?

Since this product contains an antacid ( Magnesium Hydroxide), taking it alongside other external antacids may increase the risk of excessive laxative effects or electrolyte disturbances. It can also modify absorption, potentially affecting the action of the ASA component.


Q: Is it safe to drive or operate machinery after taking Тромбитал?

According to the official product information, there are no known effects of this medicine on the ability to drive or operate machinery that would typically require a specific warning on the label.


Q: What should I do if I notice unusual black stools while on Тромбитал?

Black, tarry, or bloody stools are listed as signs of a serious side effect, which may indicate internal bleeding ( hemorrhage). Official product information states that individuals should seek medical attention right away if these symptoms are observed.


Q: Is Тромбитал safe for people with asthma or allergies?

Official regulatory information states that this product is strictly contraindicated and should not be used by individuals with a history of asthma, hives, or allergic-type reactions to Aspirin or other Nonsteroidal Anti-inflammatory Drugs ( NSAIDs).


Q: Does Тромбитал affect liver function test results?

The ASA component has the potential to cause hepatotoxicity (liver damage). Patients are typically monitored for abnormal liver tests and symptoms of liver disease (e.g., yellowing of skin or eyes). Severe liver disease is also listed as a contraindication.


Q: What's the difference between enteric-coated and plain aspirin tablets?

Enteric-coated tablets have a protective barrier that prevents the tablet from dissolving in the acidic environment of the stomach. It is designed to dissolve only in the intestine, a strategy intended to reduce the risk of gastric irritation compared to plain (non-coated) ASA tablets.


Q: Are there any known long-term drug resistance issues with Тромбитал?

The antiplatelet action of Acetylsalicylic Acid ( ASA) is described as the irreversible inactivation of an enzyme in platelets. This means the affected platelets are permanently deficient. Due to this unique, irreversible mechanism, the drug is not typically associated with classic drug resistance over time.


Q: Are there any long-term side effects associated with Тромбитал?

The most significant long-term risk associated with the ASA component is an increased risk of gastrointestinal bleeding and hemorrhage. Other documented side effects, such as tinnitus (ringing in the ears), may also be a concern with extended use.


Q: Do older people need a different dosage of Тромбитал?

Official guidelines generally recommend the usual adult dose for older patients, provided there is no severe renal (kidney) or hepatic (liver) impairment. Caution is required for use in this population, as older patients may be more susceptible to adverse events, such as GI bleeding.


Q: Can women who are planning pregnancy take Тромбитал?

The use of low-dose ASA is a specialized treatment that is sometimes recommended by a doctor for women who are planning or are in the early stages of pregnancy due to specific medical conditions. The decision to use this product should be made in consultation with a healthcare professional based on individual circumstances.


Q: Is Тромбитал available without a prescription?

While low-dose ASA-containing products are commonly available for non-prescription (over-the-counter) use, the use of this specific combination product for long-term cardiovascular prevention is a medical decision. Therefore, it is important to consult a healthcare professional before starting treatment.

How should Тромбитал be stored and disposed of?

The official regulatory requirements for Тромбитал (Acetylsalicylic Acid and Magnesium Hydroxide) define strict conditions for its storage and disposal to maintain product quality and safety.

Storage Requirements

Condition Official Regulatory Wording
Temperature Store the product below 25 C; do not freeze or refrigerate.
Protection Protect from moisture and excessive heat.
Packaging Keep the medicine in the original package and ensure the container is tightly closed.
Safety Keep out of the sight and reach of children.

Disposal Instructions

Official disposal rules require the use of pharmaceutical waste programs. Medicines must not be thrown into household trash or wastewater (e.g., flushed down the toilet). Any unused or expired product must be disposed of according to local regulatory requirements established for pharmaceutical waste collection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Тромбитал found in:

A-Z Index: